Loading clinical trials...
Loading clinical trials...
Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivity to radiation.
Age
21 - 99 years
Sex
ALL
Healthy Volunteers
No
National Cancer Center Singapore
Singapore, Singapore
Start Date
September 30, 2015
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
June 11, 2025
5,000
ESTIMATED participants
Lead Sponsor
National Cancer Centre, Singapore
Collaborators
NCT04550494
NCT05691465
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions